{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:27:54Z","timestamp":1779157674059,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/igc.0b013e31828c8619","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T17:38:07Z","timestamp":1363973887000},"page":"735-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Significance of Yes-Associated Protein Overexpression in Cervical Carcinoma"],"prefix":"10.1016","volume":"23","author":[{"given":"Tianbo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31828c8619_bb0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00130404-200309000-00003","article-title":"Pathology of cervical cancer","volume":"9","author":"Silverberg","year":"2003","journal-title":"Cancer J."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0015","first-page":"5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0025","first-page":"7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0030","first-page":"2145","article-title":"Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product","volume":"9","author":"Sudol","year":"1994","journal-title":"Oncogene."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0035","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0040","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/cncr.24495","article-title":"Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma","volume":"115","author":"Xu","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0045","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","article-title":"Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach","volume":"125","author":"Zender","year":"2006","journal-title":"Cell."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0050","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1038\/sj.onc.1208601","article-title":"Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma","volume":"24","author":"Snijders","year":"2005","journal-title":"Oncogene."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0055","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1101\/gad.1824509","article-title":"YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation","volume":"23","author":"Fernandez-L","year":"2009","journal-title":"Genes Dev."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/carcin\/bgq254","article-title":"YAP is a candidate oncogene for esophageal squamous cell carcinoma","volume":"32","author":"Muramatsu","year":"2011","journal-title":"Carcinogenesis."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0065","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","article-title":"Overexpression of Yes-associated protein contributes to progression and poor prognosis of non\u2013small-cell lung cancer","volume":"101","author":"Wang","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0070","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/onc.2011.8","article-title":"The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0075","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-10-2467","article-title":"Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis","volume":"17","author":"Kang","year":"2011","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/cdd.2008.108","article-title":"Yes-associated protein (YAP) functions as a tumor suppressor in breast","volume":"15","author":"Yuan","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0085","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/NEN.0b013e31821ff8d8","article-title":"Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth","volume":"70","author":"Orr","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0095","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.humpath.2008.04.012","article-title":"Expression of Yes-associated protein in common solid tumors","volume":"39","author":"Steinhardt","year":"2008","journal-title":"Hum Pathol."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0100","article-title":"Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis","volume":"6","author":"GeL","year":"2011","journal-title":"PloS One."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.humpath.2010.08.003","article-title":"Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma","volume":"42","author":"Kim","year":"2011","journal-title":"Hum Pathol."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0115","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in Drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0120","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M709037200","article-title":"Tumor suppressor LATS1 is a negative regulator of oncogene YAP","volume":"283","author":"Hao","year":"2008","journal-title":"J Biol Chem."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0125","doi-asserted-by":"crossref","first-page":"12405","DOI":"10.1073\/pnas.0605579103","article-title":"Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon","volume":"103","author":"Overholtzer","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/cc.9.1.10321","article-title":"Yes-associated protein 1 regulates the stability of DeltaNp63alpha","volume":"9","author":"Chatterjee","year":"2010","journal-title":"Cell Cycle."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2353\/ajpath.2008.070529","article-title":"Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation","volume":"172","author":"Martinez-Ferrer","year":"2008","journal-title":"Am J Pathol."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0140","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1158\/0008-5472.CAN-07-6289","article-title":"Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity","volume":"68","author":"Placencio","year":"2008","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012920","article-title":"Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth","volume":"5","author":"Placencio","year":"2010","journal-title":"PLoS One."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0150","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1158\/0008-5472.CAN-10-1345","article-title":"Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway","volume":"70","author":"Huntoon","year":"2010","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31828c8619_bb0155","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1074\/jbc.C110.205401","article-title":"Angiomotin-like proteins associate with and negatively regulate YAP1","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24019364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24019364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:35:55Z","timestamp":1753101355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24019364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1048891X24019364"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31828c8619","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Significance of Yes-Associated Protein Overexpression in Cervical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31828c8619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}